2022/12/05
Investor Relations
M3 Acquires Remedium in the U.K. ~ New Entry into International Physician Recruiting Business ~
2022/11/02
Investor Relations
[FY2022 Q2] Summary of Consolidated Financial Results
2022/11/02
Investor Relations
[FY2022 Q2] M3 Presentation Material
2022/10/31
Investor Relations
White Jack Project Phase 4, 'EBHS Life' launched; New health indicator ~ Predicting relative life expectancy based on the results of health check-ups and lifestyle habits, promoting health management and improving the health of consumers ~
2022/09/30
Investor Relations
Full launch of M3 Cancer Prevention Program for Corporations ~3rd phase of the White Jack Project: Accelerating measures to combat a national disease affecting 1 out of 2 people~
2022/09/28
Investor Relations
M3 Acquires Rinkai Medical Service, Health Checkup Service Provider ~ Further initiative in the field of preventive medicine as Phase 2 of “White-Jack Project” ~
2022/09/01
Investor Relations
"RECELL® Autologous Cell Harvesting Device" Insurance Coverage Begins in Japan ~ Medical Device for Acute Burns and Donor Sites ~
2022/07/27
Investor Relations
[FY2022 Q1] Summary of Consolidated Financial Results
2022/07/27
Investor Relations
[FY2022 Q1] M3 Presentation Material
2022/07/27
Investor Relations
M3 Launches “White-Jack Project,” an Initiative in the Field of Preventive Medicine ~ Acquiring Health Checkup Service Provider, Happiness-i, as Project Phase1 ~
2022/06/08
Investor Relations
M3 acquires iDoctus, the leading HCP point-of-care mobile app operator in Spain, Mexico and rest of Latin America ~ Addition of widely used point-of-care app expands M3’s presence in key Spanish speaking regions ~
2022/05/20
Investor Relations
M3 Acquires pharma-insight GmbH in Germany ~ M3 Continues to Strengthen Capabilities and Panel with German Acquisition ~
2022/05/17
Investor Relations
M3 acquires U.S. Multi-Specialty Clinical Research Site ~ Expanding M3-Wake Research’s coverage to Florida ~
2022/04/27
Investor Relations
[FY2021 Q4] Summary of Consolidated Financial Results
2022/04/27
Investor Relations
[FY2021 Q4] M3 Presentation Material
2022/04/27
Investor Relations
Notice Concerning Differences Between Actual Consolidated and Non-consolidated Results for the Fiscal Year Ended March 31, 2022 versus the Respective Previous Fiscal Year
2022/04/25
Investor Relations
M3 Acquires Medical Accounting and EHR Business from Canon Medical Systems ~ Accelerating DX of Clinics along with M3 DigiKar, the No.1 Share Cloud EHR System ~
2022/03/29
Investor Relations
Launch of “Clinic Succession Platform” for Third-Party Accedence of Clinics ~ m3.com Platform to Support Sustainability of Medical Institutions Across Generations ~
2022/03/18
Investor Relations
Donation to Support Relief Activities in Ukraine ~ JPY 12,051,200 in Combined Donations from m3.com Members, Matched by M3 ~
2022/03/01
Investor Relations
M3 to Acquire Logic Inc. ~ Digital Transformation of Home Medical Care via SaaS for Nursing Care Facilities ~
2022/02/25
Investor Relations
"RECELL® Autologous Cell Harvesting Device" Gains Regulatory Approval in Japan ~ Medical Device for Acute Burns and Donor Sites ~
2022/02/24
Investor Relations
Notice of Amendment to Dividend Payout Forecast
2022/02/02
Investor Relations
M3 Acquires MirVracha LCC in Russia ~ Launching Full-Scale Development of Physician Platform Business in Russia ~
2022/02/02
Investor Relations
[FY2021 Q3] Summary of Consolidated Financial Results
2022/02/02
Investor Relations
[FY2021 Q3] M3 Presentation Material
2022/01/25
Investor Relations
M3 to Acquire 3H Holdings and Three Other Group Companies ~ Leading a next-generation clinical trial area leveraging largest patient recruitment panels ~
2021/12/22
Investor Relations
Launch of "Patient Centricity Promotion Center" ~ Patient-centric Drug Development by Mediscience Planning and QLife ~
2021/12/14
Investor Relations
French CME Provider ERON Santé Becomes Part of VIDAL Group ~ Becoming a Leading Provider of Online Continuing Medical Education ~
2021/12/09
Investor Relations
M3 Acquires Ekas Marketing in Australia ~ M3 Continues Expansion of Global Physician Coverage with Australian Acquisition ~
2021/11/22
Investor Relations
Notice of Selection of Prime Market in Tokyo Stock Exchange New Market Segments
2021/11/11
Investor Relations
Transfer of Shares of TamaBio to Quon Capital ~ TamaBio: Manufacturer of Artificial Biomembranes for Neurosurgery and Cardiac Surgery ~
2021/11/10
Investor Relations
“Medical Marketer” Service Tops Adoption by Over 100 Drugs ~ “Remote x Data x Personnel Pharma” Sales and Marketing Productivity Support Service ~
2021/10/27
Investor Relations
[FY2021 Q2] M3 Presentation Material
2021/10/27
Investor Relations
[FY2021 Q2] Summary of Consolidated Financial Results
2021/10/26
Investor Relations
No.1 Cloud Based EMR System “M3 DigiKar” Tops 3000 Clinic Adoptions ~ Medical Field DX Acceleration with “M3 DigiKar Smart” ~
2021/07/28
Investor Relations
[FY2021 Q1] M3 Presentation Material
2021/07/28
Investor Relations
[FY2021 Q1] Summary of Consolidated Financial Results
2021/07/15
Investor Relations
Recognition of Dilution Gains from Changes in Equity Interest Mainly Related to Medlive's Listing in Hong Kong
2021/07/01
Investor Relations
Capital Alliance with Epigno Co., Ltd ~ Accelerate DX of Talent Management for Medical Institutions ~
2021/06/24
Investor Relations
Pfizer On-boards Entire Sales Rep Force onto M3’s myMR-kun ~ Two-Way Digitalized Information Provision via Remote Detailing System ~
2021/06/18
Investor Relations
Announcement Regarding the Recognition of Gain Relating to Loss of Control Over Subsidiaries
2021/06/17
Investor Relations
M3 Acquires Stake in pA Medien GmbH to Expand Germany Business Platform ~ Investment in praktischArzt, the Leading Online Physician Recruitment Job Board in Germany ~
2021/04/23
Investor Relations
[FY2020 Q4] M3 Presentation Material
2021/04/23
Investor Relations
[FY2020 Q4] Summary of Consolidated Financial Results
2021/04/23
Investor Relations
Notice Concerning Differences Between Actual Consolidated and Non-consolidated Results for the Fiscal Year Ended March 31, 2021 versus the Respective Previous Fiscal Year
2021/04/22
Investor Relations
Launch of Cashless Payment System for Medical Facilities ~ Joint Effort Between ©Stripe and “M3 DigiKar,” the No.1 Cloud Based EHR System in Japan ~
2021/04/13
Investor Relations
Joint Development of Disease Awareness Service with Takeda ~ HAE Disease Awareness System on AskDoctors ~
2021/04/09
Investor Relations
M3 Acquires One Health Communications Holdings ~ Extending Capabilities and Reach Across UK Healthcare Professionals ~
2021/04/07
Investor Relations
m3.com Physician Membership Tops 300,000 in Japan ~ Launching M3-Labo Under “More Contributions to More Doctors” ~
2021/03/01
Investor Relations
Capital Alliance with Africa Health Holdings Limited ~ Solution for Medical Facilities, Pharmacies and Laboratories in Africa ~
2021/02/25
Investor Relations
Notice of Amendment to Dividend Payout Forecast
2021/02/18
Investor Relations
M3 to Merge Subsidiaries Mediscience Planning and MIC Medical ~ Acceleration in Optimizing Digitalized Clinical Trials ~
2021/02/08
Investor Relations
Free Provision of Entertainment Robot “aibo” to Medical Facilities ~ Stress Relief for Hospitalized COVID-19 Patients ~
2021/01/29
Investor Relations
[FY2020 Q3] M3 Presentation Material
2021/01/29
Investor Relations
[FY2020 Q3] Summary of Consolidated Financial Results
2021/01/13
Investor Relations
M3 Acquires TOWA SANGYO Co., Ltd. ~ DX Acceleration in the Medical Device Industry ~
2020/12/21
Investor Relations
Vidal Holding France Acquires MonEcho, an AI-Assisted Sonogram Software Company ~ Expansion into Ob-Gyns and Cardiology Therapy Areas in France ~
2020/12/17
Investor Relations
LINE Healthcare Launches Free “LINE Doctor” in Greater Tokyo Area ~ Service Region to Expand with Improvements ~
2020/12/14
Investor Relations
SONY and M3 Join Forces for Open Innovation Projects in Healthcare ~ Collaborative Medical Practice Advancement for Social Solutions ~
2020/12/08
Investor Relations
M3 and Nippon Boehringer Ingelheim enter into a business partnership for diagnostic support utilizing Artificial Intelligence (AI) for ILDs and other lung diseases
2020/11/12
Investor Relations
Joint Development and Distribution Agreement with Fuji Pharma ~ Collaboration of Capabilities for End-to-end Solutions ~
2020/10/30
Investor Relations
[FY2020 Q2] M3 Presentation Material
2020/10/30
Investor Relations
[FY2020 Q2] Summary of Consolidated Financial Results
2020/10/28
Investor Relations
Two New Algorithms from VUNO and LPixel to Onboard M3's AI Platform ~ Medical Image Diagnostics for Pulmonary Nodules ~ /EOM
2020/10/20
Investor Relations
No.1 Cloud Based EMR System “M3 DigiKar” Tops 2000 Clinic Adoptions ~ Managing Medical Records of Over 36 Million Patients ~
2020/09/30
Investor Relations
COVID-19 Pneumonia AI Free Provision Project Expansion and Exacerbation Prediction AI Development
2020/09/10
Investor Relations
LHC's Online Examination Service "LINE Doctor" to be Launched in November ~ FREE One-Click Clinic Search & Appointment, Consultation, and Payment Service via LINE ~